Table 3.
Distributions of the FLU-IVIG placebo group and IVIG group on day 7 of follow-up. The FLU-IVIG placebo group distribution was estimated from the cohort study [17,18].
| Death | ICU | Hospitalized, not in ICU, on oxygen | Hospitalized, not in ICU, not on oxygen | Discharged, not back to normal activities | Discharged, back to normal activities | |
|---|---|---|---|---|---|---|
| % Placeboa | 1.0 | 4.9 | 16.3 | 14.5 | 36.2 | 27.1 |
| % IVIGb | 0.6 | 2.9 | 10.4 | 10.8 | 35.6 | 39.7 |
| Odds ratioc | 1.77 | 1.77 | 1.77 | 1.77 | 1.77 | |
a
% Placebo: percentage of patients in the placebo group for the given ordinal endpoint category.
b
% IVIG: percentage of patients in the IVIG group for the given ordinal endpoint category.
c
Odds ratio: The odds of having the given ordinal endpoint category or less severe versus more severe between the IVIG and placebo groups.